SGHT Sight Sciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SGHT

Price (delayed)

$4.61

Market cap

$250.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.71

Enterprise value

$206.4M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 34
Highlights
Sight Sciences's EPS has increased by 28% YoY and by 4.1% from the previous quarter
The net income has grown by 25% YoY and by 3.1% from the previous quarter
The quick ratio has contracted by 46% YoY and by 43% from the previous quarter
Sight Sciences's equity has decreased by 31% YoY and by 16% QoQ
Sector: Healthcare
Industry: Medical Devices
Peers: OFIX

Key stats

What are the main financial stats of SGHT

SGHT stock price

How has the Sight Sciences stock price performed over time
Intraday
6.22%
1 week
-8.89%
1 month
9.24%
1 year
8.73%
YTD
-41.87%
QTD
22.28%

Financial performance

How have Sight Sciences's revenue and profit performed over time
Revenue
$79.55M
Gross profit
$68.55M
Operating income
-$35.65M
Net income
-$37.25M
Gross margin
86.2%
Net margin
-46.8%
The operating margin is up by 30% year-on-year and by 7% since the previous quarter
SGHT's operating income is up by 28% year-on-year and by 3.9% since the previous quarter
SGHT's net margin is up by 26% year-on-year and by 6% since the previous quarter
The net income has grown by 25% YoY and by 3.1% from the previous quarter

Price vs fundamentals

How does SGHT's price correlate with its fundamentals

Growth

What is Sight Sciences's growth rate over time

Valuation

What is Sight Sciences stock price valuation
P/E
N/A
P/B
4.62
P/S
3.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.59
Sight Sciences's EPS has increased by 28% YoY and by 4.1% from the previous quarter
The stock's P/B is 45% more than its 5-year quarterly average of 3.0 and 9% more than its last 4 quarters average of 4.0
Sight Sciences's equity has decreased by 31% YoY and by 16% QoQ
The stock's price to sales (P/S) is 47% less than its 5-year quarterly average of 5.5 and 11% less than its last 4 quarters average of 3.3
The revenue is up by 2.8% from the previous quarter

Efficiency

How efficient is Sight Sciences business performance
The company's return on invested capital rose by 31% YoY and by 2.9% QoQ
Sight Sciences's ROS has increased by 29% YoY and by 6% from the previous quarter
The company's return on equity fell by 8% YoY and by 6% QoQ
The ROA is up by 8% year-on-year

Dividends

What is SGHT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGHT.

Financial health

How did Sight Sciences financials performed over time
The total assets is 97% more than the total liabilities
The quick ratio has contracted by 46% YoY and by 43% from the previous quarter
Sight Sciences's current ratio has decreased by 44% YoY and by 43% QoQ
SGHT's debt is 25% smaller than its equity
SGHT's debt to equity is up by 47% year-on-year and by 19% since the previous quarter
Sight Sciences's equity has decreased by 31% YoY and by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.